Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

XUANWU CLOUD (02392) spent HKD 4585.55 on November 20th to repurchase 4000 shares.

Hainan Mining (601969.SH) shareholder Hesteel Group plans to reduce its holdings by no more than 15 million shares.

FENBI (02469) spent 634,000 Hong Kong dollars repurchasing 200,000 shares on November 20.
XUANWU CLOUD (02392) spent HKD 4585.55 on November 20th to repurchase 4000 shares.

Hainan Mining (601969.SH) shareholder Hesteel Group plans to reduce its holdings by no more than 15 million shares.

FENBI (02469) spent 634,000 Hong Kong dollars repurchasing 200,000 shares on November 20.

RECOMMEND

Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
18/11/2025

Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
18/11/2025

Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
18/11/2025


